» Articles » PMID: 38816546

Formulation and Characterization of Ethosomes for Transdermal Delivery of Prinsepia Utilis Rogle Seed Oil with Ameliorative Effects Against UVB-Induced Skin Damage

Overview
Publisher Springer
Specialty Pharmacology
Date 2024 May 30
PMID 38816546
Authors
Affiliations
Soon will be listed here.
Abstract

Prinsepia utilis seed oil (PUSO) is a natural medication obtained from Prinsepia utilis Rogle seed, which has been used for the treatment of skin diseases. The study aims to prepare ethosomes with high drug loading as a water-soluble transdermal vehicle to enhance the transdermal delivery of PUSO. PUSO-loaded ethosomes (PEs) were prepared using a cold method, and optimized by an orthogonal experimental design with entrapment efficiency (EE) as the dependent variable. The PEs prepared with the optimized formulation showed good stability, with a spherical shape under transmission electron microscopy (TEM), average particle size of 39.12 ± 0.85 nm, PDI of 0.270 ± 0.01, zeta potential of -11.3 ± 0.24 mV, and EE of 95.93 ± 0.43%. PEs significantly increased the skin deposition of PUSO compared to the PUSO suspension (P < 0.001). Moreover, the optimum formula showed significant ameliorative effects on ultraviolet B (UVB) irradiation-associated macroscopic and histopathological changes in mice skin. Therefore, PEs represent a promising therapeutic approach for the treatment of UVB-induced skin inflammation, with the potential for industrialization.

Citing Articles

The Tiny Big Difference: Nanotechnology in Photoprotective Innovations - A Systematic Review.

Nascimento Junior J, Santos A, Oliveira A, Santos A, Araujo A, Aragon D AAPS PharmSciTech. 2024; 25(7):212.

PMID: 39242428 DOI: 10.1208/s12249-024-02925-4.

References
1.
Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M . Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000; 65(3):403-18. DOI: 10.1016/s0168-3659(99)00222-9. View

2.
Esposito E, Nastruzzi C, Sguizzato M, Cortesi R . Nanomedicines to Treat Skin Pathologies with Natural Molecules. Curr Pharm Des. 2019; 25(21):2323-2337. DOI: 10.2174/1381612825666190709210703. View

3.
Ruan H, Shen L, Hou X, Li J, Guo T, Zhu C . Phytosterol-mediated glycerosomes combined with peppermint oil enhance transdermal delivery of lappaconitine by modulating the lipid composition of the stratum corneum. Drug Deliv Transl Res. 2023; 13(12):3014-3029. DOI: 10.1007/s13346-023-01371-2. View

4.
Paiva-Santos A, Silva A, Guerra C, Peixoto D, Pereira-Silva M, Zeinali M . Ethosomes as Nanocarriers for the Development of Skin Delivery Formulations. Pharm Res. 2021; 38(6):947-970. DOI: 10.1007/s11095-021-03053-5. View

5.
Shumilov M, Bercovich R, Duchi S, Ainbinder D, Touitou E . Ibuprofen transdermal ethosomal gel: characterization and efficiency in animal models. J Biomed Nanotechnol. 2011; 6(5):569-76. DOI: 10.1166/jbn.2010.1153. View